1. Home
  2. EDSA vs CARV Comparison

EDSA vs CARV Comparison

Compare EDSA & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • CARV
  • Stock Information
  • Founded
  • EDSA 2015
  • CARV 1948
  • Country
  • EDSA Canada
  • CARV United States
  • Employees
  • EDSA N/A
  • CARV N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • CARV Savings Institutions
  • Sector
  • EDSA Health Care
  • CARV Finance
  • Exchange
  • EDSA Nasdaq
  • CARV Nasdaq
  • Market Cap
  • EDSA 6.2M
  • CARV 7.3M
  • IPO Year
  • EDSA N/A
  • CARV 1994
  • Fundamental
  • Price
  • EDSA $1.96
  • CARV $1.51
  • Analyst Decision
  • EDSA Strong Buy
  • CARV
  • Analyst Count
  • EDSA 1
  • CARV 0
  • Target Price
  • EDSA $21.00
  • CARV N/A
  • AVG Volume (30 Days)
  • EDSA 34.1K
  • CARV 21.8K
  • Earning Date
  • EDSA 05-14-2025
  • CARV 07-15-2025
  • Dividend Yield
  • EDSA N/A
  • CARV N/A
  • EPS Growth
  • EDSA N/A
  • CARV N/A
  • EPS
  • EDSA N/A
  • CARV N/A
  • Revenue
  • EDSA N/A
  • CARV $24,056,000.00
  • Revenue This Year
  • EDSA N/A
  • CARV N/A
  • Revenue Next Year
  • EDSA N/A
  • CARV N/A
  • P/E Ratio
  • EDSA N/A
  • CARV N/A
  • Revenue Growth
  • EDSA N/A
  • CARV N/A
  • 52 Week Low
  • EDSA $1.55
  • CARV $1.30
  • 52 Week High
  • EDSA $5.59
  • CARV $2.39
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.93
  • CARV 57.40
  • Support Level
  • EDSA $1.96
  • CARV $1.35
  • Resistance Level
  • EDSA $2.06
  • CARV $1.52
  • Average True Range (ATR)
  • EDSA 0.10
  • CARV 0.09
  • MACD
  • EDSA -0.00
  • CARV 0.01
  • Stochastic Oscillator
  • EDSA 30.77
  • CARV 84.00

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: